Wender, Paul

Publication with MATCHING institution:

Wender P, Hinkle KW, Koehler MF, Lippa B (1999) The rational design of potential chemotherapeutic agents: synthesis of
bryostatin analogues. Medicinal Research Reviews. [IF=2.965, Cited=32, 10502742].
Wender P (2001) Serial [5+2]/[4+2] Cycloadditions: Facile, Preparative, Multi-Component Syntheses of Polycyclic
Compounds from Simple, Readily Available Starting Materials. Angewandte Chemie - International Edition. [IF=2.456,
Cited=5, 29712128].
Wender P, Williams TJ (2002) [(arene)Rh(cod)]+ Complexes as catalysts for [5+2] cycloaddition reactions. Angewandte
Chemie - International Edition. [IF=2.456, Cited=35, 12458535].
Wender P, Deschamps NM (2003) The dienyl Pauson-Khand reaction. Angewandte Chemie - International Edition. [IF=2.456,
Cited=10, 12722081].
Wender P, Deschamps NM, Williams TJ (2004) Intermolecular dienyl Pauson-Khand reaction. Angewandte Chemie -
International Edition. [IF=2.456, Cited=7, 15188486].
Wender P, Croatt MP, Deschamps NM (2006) Metal-catalyzed [2+2+1] cycloadditions of 1,3-dienes, allenes, and CO.
Angewandte Chemie - International Edition. [IF=2.456, Cited=9, 16526073].
Wender P, Deschamps NM, Sun R (2006) RhI-catalyzed C-C bond activation: seven-membered ring synthesis by a [6+1]
carbonylative ring-expansion reaction of allenylcyclobutanes. Angewandte Chemie - International Edition. [IF=2.456,
Cited=22, 16683295].
Wender P, Christy JP, Lesser AB, Gieseler MT (2009) The synthesis of highly substituted cyclooctatetraene scaffolds by
metal-catalyzed [2+2+2+2] cycloadditions: studies on regioselectivity, dynamic properties, and metal chelation.
Angewandte Chemie - International Edition. [IF=2.456, Cited=17, 19739178].
Wender P, Lesser AB, Sirois LE (2012) Rhodium dinaphthocyclooctatetraene complexes: synthesis, characterization and
catalytic activity in [5+2] cycloadditions. Angewandte Chemie - International Edition. [IF=2.456, Cited=22, 22298411].
Singh J, Steck N, De D, ..., Jessen HJ (2019) A Phosphoramidite Analogue of Cyclotriphosphate Enables Iterative
Polyphosphorylations. Angewandte Chemie - International Edition. [IF=2.456, Cited=13, 30681761].
Wender P, Loy BA, Schrier AJ (2011) Translating Nature's Library: The Bryostatins and Function-Oriented Synthesis.
Israel Journal of Chemistry. [IF=0.673, Cited=22, 22661768].
Khan TK, Wender P, Alkon DL (2017) Bryostatin and its synthetic analog, picolog rescue dermal fibroblasts from prolonged
stress and contribute to survival and rejuvenation of human skin equivalents. Journal of Cellular Physiology. [IF=1.265,
Cited=1, 28590053].
Wender P, Galliher WC, Goun EA, ..., Pillow TH (2007) The design of guanidinium-rich transporters and their
internalization mechanisms. Advanced Drug Delivery Reviews. [IF=2.563, Cited=166, 18164781].
Abdelnabi R, Staveness D, Near KE, ..., Leyssen P (2016) Comparative analysis of the anti-chikungunya virus activity of
novel bryostatin analogs confirms the existence of a PKC-independent mechanism. Biochemical Pharmacology. [IF=1.155,
Cited=7, 27664855].
Abramson E, Hardman C, Shimizu AJ, ..., Kornberg MD (2021) Designed PKC-targeting bryostatin analogs modulate innate
immunity and neuroinflammation. Cell Chemical Biology. [IF=1.446, Cited=7, 33472023].
Wender P, Cooley CB, Geihe EI (2012) Beyond Cell Penetrating Peptides: Designed Molecular Transporters. Drug Discovery
Today: Technologies. [IF=1.328, Cited=21, 22712022].
Wender P, Reuber J (2011) Function Oriented Synthesis: Preparation and Initial Biological Evaluation of New A-Ring-
Modified Bryologs. Tetrahedron. [IF=0.579, Cited=4, 22247574].
Wender P (2013) Toward the Ideal Synthesis and Transformative Therapies: The Roles of Step Economy and Function Oriented
Synthesis. Tetrahedron. [IF=0.579, Cited=29, 23956471].
Boudreault PL, Mattler JK, Wender P (2015) Studies on the regio- and diastereo-selective epoxidation of daphnanes and
tiglianes. Tetrahedron Letters. [IF=0.515, Cited=4, 26034334].
Marsden MD, Wu X, Navab SM, ..., Zack JA (2018) Characterization of designed, synthetically accessible bryostatin analog
HIV latency reversing agents. Virology. [IF=0.835, Cited=23, 29800728].
Moran JA, Ranjan A, Hourani R, ..., Marsden MD (2023) Secreted factors induced by PKC modulators do not indirectly cause
HIV latency reversal. Virology. [IF=0.835, Cited=1, 36842270].
Marsden MD, Zhang TH, Du Y, ..., Zack JA (2020) Tracking HIV Rebound following Latency Reversal Using Barcoded HIV. Cell
Reports Medicine. [IF=1.969, Cited=11, 33377133].
Wender P, Galliher WC, Bhat NM, ..., Teng NNH (2012) Taxol-oligoarginine conjugates overcome drug resistance in-vitro in
human ovarian carcinoma. Gynecologic Oncology. [IF=1.438, Cited=15, 22484398].
Wender P, Jeon R (2003) Photoinduced cleavage of DNA by bromofluoroacetophenone-pyrrolecarboxamide conjugates.
Bioorganic and Medicinal Chemistry Letters. [IF=0.704, Cited=5, 12729660].
Wender P, Lippa B, Park CM, ..., Ohigashi H (1999) Selective binding of bryostatin analogues to the cysteine rich
domains of protein kinase C isozymes. Bioorganic and Medicinal Chemistry Letters. [IF=0.704, Cited=6, 10397502].
Wender P, Quiroz RV, Stevens MC (2015) Function through synthesis-informed design. Accounts of Chemical Research.
[IF=3.533, Cited=30, 25742599].
Blake TR, Haabeth OAW, Sallets A, ..., Waymouth RM (2023) Lysine-Derived Charge-Altering Releasable Transporters:
Targeted Delivery of mRNA and siRNA to the Lungs. Bioconjugate Chemistry. [IF=0.921, Cited=4, 36996808].
Hsu HT, Trantow BM, Waymouth R, ..., Wender PA (2015) Bioorthogonal Catalysis: A General Method To Evaluate Metal-
Catalyzed Reactions in Real Time in Living Systems Using a Cellular Luciferase Reporter System. Bioconjugate Chemistry.
[IF=0.921, Cited=20, 26367192].
Testa S, Haabeth OAW, Blake TR, ..., Levy R (2022) Fingolimod-Conjugated Charge-Altering Releasable Transporters
Efficiently and Specifically Deliver mRNA to Lymphocytes In Vivo and In Vitro. Biomacromolecules. [IF=1.112, Cited=6, 35748182].
Rahn HP, Sun J, Li Z, ..., Wender PA (2024) Isoprenoid CARTs: In Vitro and In Vivo mRNA Delivery by
Charge-Altering Releasable Transporters Functionalized with Archaea-inspired Branched Lipids. Biomacromolecules.
[IF=1.112, Cited=0, 38814265].
Brčić J, Tong A, Wender P, ..., Cegelski L (2023) Conjugation of Vancomycin with a Single Arginine Improves Efficacy
against Mycobacteria by More Effective Peptidoglycan Targeting. Journal of Medicinal Chemistry. [IF=1.655, Cited=2, 37477249].
Staveness D, Abdelnabi R, Schrier AJ, ..., Wender P (2016) Simplified Bryostatin Analogues Protect Cells from
Chikungunya Virus-Induced Cell Death. Journal of Natural Products. [IF=1.606, Cited=12, 26900625].
Staveness D, Abdelnabi R, Near KE, ..., Wender P (2016) Inhibition of Chikungunya Virus-Induced Cell Death by
Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway. Journal of Natural
Products. [IF=1.606, Cited=20, 26900711].
Wender P, Sloane JL, Luu-Nguyen QH, ..., Hardman C (2020) Function-Oriented Synthesis: Design, Synthesis, and Evaluation
of Highly Simplified Bryostatin Analogues. Journal of Organic Chemistry. [IF=0.885, Cited=3, 33200928].
Wender P, Luu-Nguyen QH, Sloane JL, Ranjan A (2022) Trimethylene Methane Dianion Equivalent for the Asymmetric
Consecutive Allylation of Aldehydes: Applications to Prins-Driven Macrocyclizations for the Synthesis of Bryostatin 1
and Analogues. Journal of Organic Chemistry. [IF=0.885, Cited=0, 36378802].
Wender P, Ebner C, Fennell BD, ..., Schröder B (2017) Ynol Ethers as Ketene Equivalents in Rhodium-Catalyzed
Intermolecular [5 + 2] Cycloaddition Reactions. Organic Letters. [IF=1.091, Cited=4, 29034684].
Haabeth OAW, Lohmeyer JJK, Sallets A, ..., Levy R (2021) An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable
Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory. ACS Central Science. [IF=2.363,
Cited=27, 34341771].
Liu B, Ramsundar B, Kawthekar P, ..., Pande V (2017) Retrosynthetic Reaction Prediction Using Neural Sequence-to-
Sequence Models. ACS Central Science. [IF=2.363, Cited=118, 29104927].
Yang H, Staveness D, Ryckbosch SM, ..., Cegelski L (2018) REDOR NMR Reveals Multiple Conformers for a Protein Kinase C
Ligand in a Membrane Environment. ACS Central Science. [IF=2.363, Cited=15, 29392180].
Fernandes-Cunha GM, McKinlay CJ, Vargas JR, ..., Wender PA (2018) Delivery of Inorganic Polyphosphate into Cells Using
Amphipathic Oligocarbonate Transporters. ACS Central Science. [IF=2.363, Cited=10, 30410977].
Antonoplis A, Zang X, Wegner T, ..., Cegelski L (2019) Vancomycin-Arginine Conjugate Inhibits Growth of Carbapenem-
Resistant E. coli and Targets Cell-Wall Synthesis. ACS Chemical Biology. [IF=0.963, Cited=28, 31479234].
Ly C, Shimizu AJ, Vargas MV, ..., Olson DE (2020) Bryostatin 1 Promotes Synaptogenesis and Reduces Dendritic Spine
Density in Cortical Cultures through a PKC-Dependent Mechanism. ACS Chemical Neuroscience. [IF=0.947, Cited=8, 32437156].
Chosy MB, Sun J, Rahn HP, ..., Cegelski L (2024) Vancomycin-Polyguanidino Dendrimer Conjugates Inhibit Growth of
Antibiotic-Resistant Gram-Positive and Gram-Negative Bacteria and Eradicate Biofilm-Associated S. aureus. ACS
Infectious Diseases. [IF=0.991, Cited=0, 38252999].
Stanzl EG, Trantow BM, Vargas JR, Wender P (2013) Fifteen years of cell-penetrating, guanidinium-rich molecular
transporters: basic science, research tools, and clinical applications. Accounts of Chemical Research. [IF=3.533,
Cited=134, 23697862].
Wender P, Verma VA, Paxton TJ, Pillow TH (2007) Function-oriented synthesis, step economy, and drug design. Accounts of
Chemical Research. [IF=3.533, Cited=361, 18159936].
Goun EA, Shinde R, Dehnert KW, ..., Franc BL (2006) Intracellular cargo delivery by an octaarginine transporter adapted
to target prostate cancer cells through cell surface protease activation. Bioconjugate Chemistry. [IF=0.921, Cited=36, 16704219].
Wender P (1996) Introduction: Frontiers in Organic Synthesis. Chemical Reviews. [IF=11.712, Cited=26, 11848741].
Mustard TJL, Wender P, Cheong PHY (2015) Catalytic Efficiency Is a Function of How Rhodium(I) (5 + 2) Catalysts
Accommodate a Conserved Substrate Transition State Geometry: Induced Fit Model for Explaining Transition Metal
Catalysis. ACS Catalysis. [IF=2.134, Cited=9, 26146588].
Wender P, Barzilay CM, Dyckman AJ (2001) The first intermolecular transition metal-catalyzed [5+2] cycloadditions with
simple, unactivated, vinylcyclopropanes. Journal of the American Chemical Society. [IF=2.573, Cited=42, 11273617].
Wender P, Hubbard RD, Zhang L (2002) Three-component cycloadditions: the first transition metal-catalyzed [5+2+1]
cycloaddition reactions. Journal of the American Chemical Society. [IF=2.573, Cited=46, 11902870].
Wender P, Hegde SG, Hubbard RD, Zhang L (2002) Total synthesis of (-)-laulimalide. Journal of the American Chemical
Society. [IF=2.573, Cited=21, 11982349].
Wender P, Baryza JL, Bennett CE, ..., Turner TM (2002) The practical synthesis of a novel and highly potent analogue of
bryostatin. Journal of the American Chemical Society. [IF=2.573, Cited=65, 12431074].
Wender P, Rothbard JB, Jessop TC, ..., Wylie BL (2002) Oligocarbamate molecular transporters: design, synthesis, and
biological evaluation of a new class of transporters for drug delivery. Journal of the American Chemical Society.
[IF=2.573, Cited=90, 12418880].
Wender P, Pedersen TM (2002) Transition metal-catalyzed hetero-[5 + 2] cycloadditions of cyclopropyl imines and alkynes:
dihydroazepines from simple, readily available starting materials. Journal of the American Chemical Society. [IF=2.573,
Cited=44, 12487573].
Wender P, Hubbard RD, Pham SM, Zhang L (2005) Multicomponent cycloadditions: the four-component [5+1+2+1] cycloaddition
of vinylcyclopropanes, alkynes, and CO. Journal of the American Chemical Society. [IF=2.573, Cited=48, 15740103].
Wegner HA, de Meijere A, Wender P (2005) Transition metal-catalyzed intermolecular [5+2] and [5+2+1] cycloadditions of
allenes and vinylcyclopropanes. Journal of the American Chemical Society. [IF=2.573, Cited=52, 15869263].
Rothbard JB, Jessop TC, Lewis RS, ..., Wender P (2004) Role of membrane potential and hydrogen bonding in the mechanism
of translocation of guanidinium-rich peptides into cells. Journal of the American Chemical Society. [IF=2.573,
Cited=262, 15291531].
Shi Kam NW, Jessop TC, Wender P, Dai H (2004) Nanotube molecular transporters: internalization of carbon nanotube-
protein conjugates into Mammalian cells. Journal of the American Chemical Society. [IF=2.573, Cited=415, 15174838].
Yu ZX, Wender P, Houk KN (2004) On the mechanism of [Rh(CO)2Cl]2-catalyzed intermolecular (5 + 2) reactions between
vinylcyclopropanes and alkynes. Journal of the American Chemical Society. [IF=2.573, Cited=59, 15281784].
Wender P, Croatt MP, Deschamps NM (2004) Rhodium(I)-catalyzed [2+2+1] cycloadditions of 1,3-dienes, alkenes, and CO.
Journal of the American Chemical Society. [IF=2.573, Cited=15, 15137743].
Wender P, Haustedt LO, Lim J, ..., Yoon JY (2006) Asymmetric catalysis of the [5 + 2] cycloaddition reaction of
vinylcyclopropanes and pi-systems. Journal of the American Chemical Society. [IF=2.573, Cited=61, 16683779].
Jones LR, Goun EA, Shinde R, ..., Wender P (2006) Releasable luciferin-transporter conjugates: tools for the real-time
analysis of cellular uptake and release. Journal of the American Chemical Society. [IF=2.573, Cited=68, 16704230].
Wender P, Christy JP (2006) Rhodium(I)-catalyzed [4+2+2] cycloadditions of 1,3-dienes, alkenes, and alkynes for the
synthesis of cyclooctadienes. Journal of the American Chemical Society. [IF=2.573, Cited=17, 16620102].
Wender P, Paxton TJ, Williams TJ (2006) Cyclopentadienone synthesis by rhodium(I)-catalyzed [3 + 2] cycloaddition
reactions of cyclopropenones and alkynes. Journal of the American Chemical Society. [IF=2.573, Cited=25, 17105285].
Wang Y, Wang J, Su J, ..., Yu ZX (2007) A computationally designed Rh(I)-catalyzed two-component [5+2+1] cycloaddition
of ene-vinylcyclopropanes and CO for the synthesis of cyclooctenones. Journal of the American Chemical Society.
[IF=2.573, Cited=55, 17655302].
Wender P, Christy JP (2007) Nickel(0)-catalyzed [2 + 2 + 2 + 2] cycloadditions of terminal diynes for the synthesis of
substituted cyclooctatetraenes. Journal of the American Chemical Society. [IF=2.573, Cited=17, 17929819].
Yu ZX, Cheong PHY, Liu P, ..., Houk KN (2008) Origins of differences in reactivities of alkenes, alkynes, and allenes in
[Rh(CO)2Cl]2-catalyzed (5 + 2) cycloaddition reactions with vinylcyclopropanes. Journal of the American Chemical
Society. [IF=2.573, Cited=53, 18251468].
Liu P, Sirois LE, Cheong PHY, ..., Houk KN (2010) Electronic and steric control of regioselectivities in Rh(I)-catalyzed
(5 + 2) cycloadditions: experiment and theory. Journal of the American Chemical Society. [IF=2.573, Cited=51, 20586494].
Wender P, Schrier AJ (2011) Total synthesis of bryostatin 9. Journal of the American Chemical Society. [IF=2.573,
Cited=53, 21618969].
Xu X, Liu P, Lesser A, ..., Houk KN (2012) Ligand effects on rates and regioselectivities of Rh(I)-catalyzed (5 + 2)
cycloadditions: a computational study of cyclooctadiene and dinaphthocyclooctatetraene as ligands. Journal of the
American Chemical Society. [IF=2.573, Cited=41, 22668243].
Hong X, Stevens MC, Liu P, ..., Houk KN (2014) Reactivity and chemoselectivity of allenes in Rh(I)-catalyzed
intermolecular (5 + 2) cycloadditions with vinylcyclopropanes: allene-mediated rhodacycle formation can poison
Rh(I)-catalyzed cycloadditions. Journal of the American Chemical Society. [IF=2.573, Cited=23, 25379606].
Lee HL, Dubikovskaya EA, Hwang H, ..., Wender P (2008) Single-molecule motions of oligoarginine transporter conjugates
on the plasma membrane of Chinese hamster ovary cells. Journal of the American Chemical Society. [IF=2.573, Cited=27, 18578528].
Wender P, Dechristopher BA, Schrier AJ (2008) Efficient synthetic access to a new family of highly potent bryostatin
analogues via a Prins-driven macrocyclization strategy. Journal of the American Chemical Society. [IF=2.573, Cited=66, 18452292].
Wender P, Strand D (2009) Cyclocarboamination of alkynes with aziridines: synthesis of 2,3-dihydropyrroles by a
catalyzed formal [3 + 2] cycloaddition. Journal of the American Chemical Society. [IF=2.573, Cited=33, 19489638].
Cooley CB, Trantow BM, Nederberg F, ..., Wender PA (2009) Oligocarbonate molecular transporters: oligomerization-based
syntheses and cell-penetrating studies. Journal of the American Chemical Society. [IF=2.573, Cited=48, 19860416].
Wender P, Stemmler RT, Sirois LE (2010) A metal-catalyzed intermolecular [5+2] cycloaddition/Nazarov cyclization
sequence and cascade. Journal of the American Chemical Society. [IF=2.573, Cited=38, 20141136].
Li Z, Amaya L, Ee A, ..., Wender PA (2024) Organ- and Cell-Selective Delivery of mRNA In Vivo Using Guanidinylated
Serinol Charge-Altering Releasable Transporters. Journal of the American Chemical Society. [IF=2.573, Cited=0, 38743019].
Rahn HP, Liu X, Chosy MB, ..., Wender PA (2024) Biguanide-Vancomycin Conjugates are Effective Broad-Spectrum Antibiotics
against Actively Growing and Biofilm-Associated Gram-Positive and Gram-Negative ESKAPE Pathogens and Mycobacteria.
Journal of the American Chemical Society. [IF=2.573, Cited=0, 39088791].
Loy BA, Lesser AB, Staveness D, ..., Wender PA (2015) Toward a biorelevant structure of protein kinase C bound
modulators: design, synthesis, and evaluation of labeled bryostatin analogues for analysis with rotational echo double
resonance NMR spectroscopy. Journal of the American Chemical Society. [IF=2.573, Cited=14, 25710634].
Wender P, Jeffreys MS, Raub AG (2015) Tetramethyleneethane Equivalents: Recursive Reagents for Serialized
Cycloadditions. Journal of the American Chemical Society. [IF=2.573, Cited=9, 25961416].
McKinlay CJ, Waymouth R, Waymouth RM, ..., Wender PA (2016) Cell-Penetrating, Guanidinium-Rich Oligophosphoesters:
Effective and Versatile Molecular Transporters for Drug and Probe Delivery. Journal of the American Chemical Society.
[IF=2.573, Cited=27, 26900771].
Antonoplis A, Zang X, Huttner MA, ..., Cegelski L (2018) A Dual-Function Antibiotic-Transporter Conjugate Exhibits
Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells. Journal of the American Chemical Society.
[IF=2.573, Cited=38, 30388366].
Benner NL, McClellan RL, Turlington CR, ..., Wender PA (2019) Oligo(serine ester) Charge-Altering Releasable
Transporters: Organocatalytic Ring-Opening Polymerization and their Use for in Vitro and in Vivo mRNA Delivery. Journal
of the American Chemical Society. [IF=2.573, Cited=26, 31083999].
Singh J, Ripp A, Haas TM, ..., Jessen HJ (2019) Synthesis of Modified Nucleoside Oligophosphates Simplified: Fast, Pure,
and Protecting Group Free. Journal of the American Chemical Society. [IF=2.573, Cited=13, 31512870].
Rothbard JB, Kreider E, VanDeusen CL, ..., Wender P (2002) Arginine-rich molecular transporters for drug delivery: role
of backbone spacing in cellular uptake. Journal of Medicinal Chemistry. [IF=1.655, Cited=150, 12166934].
Stone JC, Stang SL, Zheng Y, ..., Wender P (2004) Synthetic bryostatin analogues activate the RasGRP1 signaling pathway.
Journal of Medicinal Chemistry. [IF=1.655, Cited=15, 15588099].
Ogawa Y, Painter PP, Tantillo DJ, Wender P (2012) Mechanistic and computational studies of exocyclic stereocontrol in
the synthesis of bryostatin-like cis-2,6-disubstituted 4-alkylidenetetrahydropyrans by Prins cyclization. Journal of
Organic Chemistry. [IF=0.885, Cited=6, 23121542].
Wender P, Glass TE, Mühlebach M, Peschke B (1996) The Pinene Path to Taxanes. 4. Approaches to Taxol and Taxol Analogs
through Elaboration of Aromatic C-Ring Precursors. Journal of Organic Chemistry. [IF=0.885, Cited=3, 11667717].
Clark EA, Hills PM, Davidson BS, ..., Mooberry SL (2006) Laulimalide and synthetic laulimalide analogues are synergistic
with paclitaxel and 2-methoxyestradiol. Molecular Pharmaceutics. [IF=1.039, Cited=26, 16889440].
Vargas JR, Stanzl EG, Teng NNH, Wender P (2014) Cell-penetrating, guanidinium-rich molecular transporters for overcoming
efflux-mediated multidrug resistance. Molecular Pharmaceutics. [IF=1.039, Cited=28, 24798708].
Wender P, Huttner MA, Staveness D, ..., Xu AF (2015) Guanidinium-rich, glycerol-derived oligocarbonates: a new class of
cell-penetrating molecular transporters that complex, deliver, and release siRNA. Molecular Pharmaceutics. [IF=1.039,
Cited=13, 25588140].
Mooberry SL, Hilinski MK, Clark EA, Wender P (2008) Function-oriented synthesis: biological evaluation of laulimalide
analogues derived from a last step cross metathesis diversification strategy. Molecular Pharmaceutics. [IF=1.039,
Cited=7, 18662015].
Buehler DC, Marsden MD, Shen S, ..., Rome LH (2014) Bioengineered vaults: self-assembling protein shell-lipophilic core
nanoparticles for drug delivery. ACS Nano. [IF=2.423, Cited=27, 25061969].
Lewis CA, Longcore KE, Miller S, ..., Wender PA (2009) An approach to the site-selective diversification of apoptolidin
A with peptide-based catalysts. Journal of Natural Products. [IF=1.606, Cited=41, 19769383].
Wender P, Dyckman A, Husfeld C, Scanio M (2000) A new and practical five-carbon component for metal-catalyzed. Organic
Letters. [IF=1.091, Cited=22, 10841491].
Wender P, Zhang L (2000) Asymmetric total synthesis of (+)-aphanamol I based on the transition metal catalyzed [5 + 2]
cycloaddition of allenes and vinylcyclopropanes. Organic Letters. [IF=1.091, Cited=30, 10930274].
Wender P, Bi FC, Brodney MA, Gosselin F (2001) Asymmetric synthesis of the tricyclic core of NGF-inducing cyathane
diterpenes via a transition-metal-catalyzed [5 + 2] cycloaddition. Organic Letters. [IF=1.091, Cited=24, 11418060].
Wender P, Jessop TC, Pattabiraman K, ..., VanDeusen CL (2001) An efficient, scalable synthesis of the molecular
transporter octaarginine via a segment doubling strategy. Organic Letters. [IF=1.091, Cited=20, 11594801].
Wender P, Gulledge AV, Jankowski OD, Seto H (2002) Isoapoptolidin: structure and activity of the ring-expanded isomer of
apoptolidin. Organic Letters. [IF=1.091, Cited=23, 12599467].
Wender P, Mayweg AVW, VanDeusen CL (2003) A concise, selective synthesis of the polyketide spacer domain of a potent
bryostatin analogue. Organic Letters. [IF=1.091, Cited=8, 12556171].
Wender P, Jankowski OD, Tabet EA, Seto H (2003) Toward a structure-activity relationship for apoptolidin: selective
functionalization of the hydroxyl group array. Organic Letters. [IF=1.091, Cited=17, 12583750].
Wender P, Jankowski OD, Tabet EA, Seto H (2003) Facile synthetic access to and biological evaluation of the macrocyclic
core of apoptolidin. Organic Letters. [IF=1.091, Cited=17, 12816433].
Kirschberg TA, VanDeusen CL, Rothbard JB, ..., Wender P (2003) Arginine-based molecular transporters: the synthesis and
chemical evaluation of releasable taxol-transporter conjugates. Organic Letters. [IF=1.091, Cited=33, 12967299].
Wender P, Hegde SG, Hubbard RD, ..., Mooberry SL (2003) Synthesis and biological evaluation of (-)-laulimalide
analogues. Organic Letters. [IF=1.091, Cited=21, 12967311].
Wender P, Koehler MFT, Sendzik M (2003) A new synthetic approach to the C ring of known as well as novel bryostatin
analogues. Organic Letters. [IF=1.091, Cited=10, 14627380].
Wender P, Hilinski MK, Mayweg AVW (2005) Late-stage intermolecular CH activation for lead diversification: a highly
chemoselective oxyfunctionalization of the C-9 position of potent bryostatin analogues. Organic Letters. [IF=1.091,
Cited=45, 15624982].
Wender P, Baryza JL (2005) Identification of a tunable site in bryostatin analogs: C20 Bryologs through late stage
diversification. Organic Letters. [IF=1.091, Cited=8, 15760168].
Wender P, Clarke MO, Horan JC (2005) Role of the A-ring of bryostatin analogues in PKC binding: synthesis and initial
biological evaluation of new A-ring-modified bryologs. Organic Letters. [IF=1.091, Cited=9, 15876038].
Wender P, Sukopp M, Longcore K (2005) Apoptolidins B and C: isolation, structure determination, and biological activity.
Organic Letters. [IF=1.091, Cited=23, 15987196].
Wender P, Kreider E, Pelkey ET, ..., Vandeusen CL (2005) Dendrimeric molecular transporters: synthesis and evaluation of
tunable polyguanidino dendrimers that facilitate cellular uptake. Organic Letters. [IF=1.091, Cited=29, 16235896].
Wender P, Jankowski OD, Longcore K, ..., Tomikawa T (2006) Correlation of F0F1-ATPase inhibition and antiproliferative
activity of apoptolidin analogues. Organic Letters. [IF=1.091, Cited=19, 16468718].
Wender P, Hilinski MK, Soldermann N, Mooberry SL (2006) Total synthesis and biological evaluation of
11-desmethyllaulimalide, a highly potent simplified laulimalide analogue. Organic Letters. [IF=1.091, Cited=10, 16562928].
Wender P, Verma VA (2006) Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of
bryostatin. Organic Letters. [IF=1.091, Cited=20, 16623578].
Wender P, Hilinski MK, Skaanderup PR, ..., Mooberry SL (2006) Pharmacophore mapping in the laulimalide series: total
synthesis of a vinylogue for a late-stage metathesis diversification strategy. Organic Letters. [IF=1.091, Cited=12, 16928085].
Wender P, Horan JC (2006) Synthesis and PKC binding of a new class of a-ring diversifiable bryostatin analogues
utilizing a double asymmetric hydrogenation and cross-coupling strategy. Organic Letters. [IF=1.091, Cited=15, 16986955].
Wender P, Horan JC, Verma VA (2006) Total synthesis and initial biological evaluation of new B-ring-modified bryostatin
analogs. Organic Letters. [IF=1.091, Cited=18, 17078702].
Wender P, Bi FC, Buschmann N, ..., Ohmura H (2006) Studies on oxidopyrylium [5+2] cycloadditions: toward a general
synthetic route to the C12-hydroxydaphnetoxins. Organic Letters. [IF=1.091, Cited=18, 17078721].
Wender P, Longcore KE (2007) Isolation, structure determination, and anti-cancer activity of apoptolidin D. Organic
Letters. [IF=1.091, Cited=18, 17286376].
Wender P, D'Angelo N, Elitzin VI, ..., Voigtlaender D (2007) Function-oriented synthesis: studies aimed at the synthesis
and mode of action of 1alpha-alkyldaphnane analogues. Organic Letters. [IF=1.091, Cited=14, 17408281].
Wender P, Sirois LE, Stemmler RT, Williams TJ (2010) Highly efficient, facile, room temperature intermolecular [5 + 2]
cycloadditions catalyzed by cationic rhodium(I): one step to cycloheptenes and their libraries. Organic Letters.
[IF=1.091, Cited=20, 20196579].
Wender P, Inagaki F, Pfaffenbach M, Stevens MC (2014) Propargyltrimethylsilanes as allene equivalents in transition
metal-catalyzed [5 + 2] cycloadditions. Organic Letters. [IF=1.091, Cited=10, 24819093].
Wender P, Nakagawa Y, Near KE, Staveness D (2014) Computer-guided design, synthesis, and protein kinase C affinity of a
new salicylate-based class of bryostatin analogs. Organic Letters. [IF=1.091, Cited=21, 25238583].
Wender P, Staveness D (2014) Improved protein kinase C affinity through final step diversification of a simplified
salicylate-derived bryostatin analog scaffold. Organic Letters. [IF=1.091, Cited=12, 25238640].
Wender P, Verma VA (2008) The design, synthesis, and evaluation of C7 diversified bryostatin analogs reveals a hot spot
for PKC affinity. Organic Letters. [IF=1.091, Cited=24, 18588309].
Wender P, Longcore KE (2009) Apoptolidins E and F, new glycosylated macrolactones isolated from Nocardiopsis sp. Organic
Letters. [IF=1.091, Cited=13, 19943700].
Wender P, Jeon R (1999) Bromoacetophenone-based photonucleases: photoinduced cleavage of DNA by 4'-bromoacetophenone-
pyrrolecarboxamide conjugates. Organic Letters. [IF=1.091, Cited=9, 10836065].
Wender P, Kirschberg TA, Williams PD, ..., Irie K (1999) A new class of simplified phorbol ester analogues: synthesis
and binding to PKC and eta PKC-C1B (eta PKC-CRD2). Organic Letters. [IF=1.091, Cited=2, 10825954].
Wender P, Miller BL (2009) Synthesis at the molecular frontier. Nature. [IF=11.591, Cited=166, 19587760].
Wender P (2017) Gilbert Stork (1921-2017). Nature. [IF=11.591, Cited=0, 29189811].
Wender P, Buschmann N, Cardin NB, ..., Longcore KE (2011) Gateway synthesis of daphnane congeners and their protein
kinase C affinities and cell-growth activities. Nature Chemistry. [IF=3.667, Cited=33, 21778981].
Wender P, Fournogerakis DN, Jeffreys MS, ..., Pfaffenbach M (2014) Structural complexity through multicomponent
cycloaddition cascades enabled by dual-purpose, reactivity regenerating 1,2,3-triene equivalents. Nature Chemistry.
[IF=3.667, Cited=22, 24755598].
Pavlovic I, Thakor DT, Vargas JR, ..., Jessen HJ (2016) Cellular delivery and photochemical release of a caged inositol-
pyrophosphate induces PH-domain translocation in cellulo. Nature Communications. [IF=3.268, Cited=50, 26842801].
Ryckbosch SM, Wender P, Pande VS (2017) Molecular dynamics simulations reveal ligand-controlled positioning of a
peripheral protein complex in membranes. Nature Communications. [IF=3.268, Cited=33, 28232750].
Hardman C, Ho S, Shimizu A, ..., Wender P (2020) Synthesis and evaluation of designed PKC modulators for enhanced cancer
immunotherapy. Nature Communications. [IF=3.268, Cited=17, 32312992].
Kim JT, Zhang TH, Carmona C, ..., Zack JA (2022) Latency reversal plus natural killer cells diminish HIV reservoir in
vivo. Nature Communications. [IF=3.268, Cited=29, 35013215].
Li Z, Amaya L, Pi R, ..., Wender PA (2023) Charge-altering releasable transporters enhance mRNA delivery in vitro and
exhibit in vivo tropism. Nature Communications. [IF=3.268, Cited=4, 37914693].
Wender P, Gentry ZO, Fanelli DJ, ..., Njoo E (2022) Practical synthesis of the therapeutic leads tigilanol tiglate and
its analogues. Nature Chemistry. [IF=3.667, Cited=1, 36192432].
Chen R, Wang SK, Belk JA, ..., Chang HY (2022) Engineering circular RNA for enhanced protein production. Nature
Biotechnology. [IF=8.861, Cited=71, 35851375].
Chen R, Wang SK, Belk JA, ..., Chang HY (2023) Author Correction: Engineering circular RNA for enhanced protein
production. Nature Biotechnology. [IF=8.861, Cited=2, 35978134].
Albert BJ, Niu A, Ramani R, ..., Kyei GB (2017) Combinations of isoform-targeted histone deacetylase inhibitors and
bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation. Scientific
Reports. [IF=1.312, Cited=26, 28785069].
Wender P (2014) Toward the ideal synthesis and molecular function through synthesis-informed design. Natural Product
Reports. [IF=3.292, Cited=51, 24589860].
Wender P, Axtman AD, Golden JE, ..., Stevens MC (2014) Function through bio-inspired, synthesis-informed design: step-
economical syntheses of designed kinase inhibitors†Dedicated to Max Malacria, a friend and scholar whose science and
creative contributions to step-economical synthesis have inspired us all and moved the field closer to the
ideal.‡Electronic supplementary information (ESI) available: Synthetic procedures and spectral data. See DOI:
10.1039/c4qo00228hClick here for additional data file. Organic Chemistry Frontiers. [IF=1.004, Cited=3, 25632347].
Habibian M, McKinlay C, Blake TR, ..., Kool ET (2019) Reversible RNA acylation for control of CRISPR-Cas9 gene editing.
Chemical Science. [IF=1.563, Cited=20, 34084356].
Blake TR, Ho WC, Turlington CR, ..., Waymouth RM (2020) Synthesis and mechanistic investigations of pH-responsive
cationic poly(aminoester)s. Chemical Science. [IF=1.563, Cited=10, 34122796].
Werby SH, Brčić J, Chosy MB, ..., Cegelski L (2023) Detection of intact vancomycin-arginine as the active antibacterial
conjugate in E. coli by whole-cell solid-state NMR. RSC Medicinal Chemistry. [IF=1.125, Cited=0, 37360389].
Wender P, Billingsley KL (2013) Lead Diversification through a Prins-Driven Macrocyclization Strategy: Application to
C13-Diversified Bryostatin Analogues. Synthesis. [IF=0.648, Cited=2, 24672140].
Mooberry SL, Randall-Hlubek DA, Leal RM, ..., Wender P (2004) Microtubule-stabilizing agents based on designed
laulimalide analogues. Proceedings of the National Academy of Sciences of the United States of America. [IF=2.765,
Cited=33, 15161976].
Wender P, Goun EA, Jones LR, ..., Contag CH (2007) Real-time analysis of uptake and bioactivatable cleavage of
luciferin-transporter conjugates in transgenic reporter mice. Proceedings of the National Academy of Sciences of the
United States of America. [IF=2.765, Cited=44, 17563383].
Wender P, Baryza JL, Brenner SE, ..., Verma VA (2011) Design, synthesis, and evaluation of potent bryostatin analogs
that modulate PKC translocation selectivity. Proceedings of the National Academy of Sciences of the United States of
America. [IF=2.765, Cited=54, 21415363].
Hyman JM, Geihe EI, Trantow BM, ..., Wender P (2012) A molecular method for the delivery of small molecules and proteins
across the cell wall of algae using molecular transporters. Proceedings of the National Academy of Sciences of the
United States of America. [IF=2.765, Cited=28, 22847404].
Geihe EI, Cooley CB, Simon JR, ..., Wender PA (2012) Designed guanidinium-rich amphipathic oligocarbonate molecular
transporters complex, deliver and release siRNA in cells. Proceedings of the National Academy of Sciences of the United
States of America. [IF=2.765, Cited=42, 22847412].
Beans EJ, Fournogerakis D, Gauntlett C, ..., Wender P (2013) Highly potent, synthetically accessible prostratin analogs
induce latent HIV expression in vitro and ex vivo. Proceedings of the National Academy of Sciences of the United States
of America. [IF=2.765, Cited=90, 23812750].
McKinlay CJ, Vargas JR, Blake TR, ..., Waymouth RM (2017) Charge-altering releasable transporters (CARTs) for the
delivery and release of mRNA in living animals. Proceedings of the National Academy of Sciences of the United States of
America. [IF=2.765, Cited=99, 28069945].
McKinlay CJ, Benner NL, Haabeth OA, ..., Wender PA (2018) Enhanced mRNA delivery into lymphocytes enabled by lipid-
varied libraries of charge-altering releasable transporters. Proceedings of the National Academy of Sciences of the
United States of America. [IF=2.765, Cited=84, 29891683].
Haabeth OAW, Blake TR, McKinlay CJ, ..., Levy R (2018) mRNA vaccination with charge-altering releasable transporters
elicits human T cell responses and cures established tumors in mice. Proceedings of the National Academy of Sciences of
the United States of America. [IF=2.765, Cited=50, 30201728].
Sloane JL, Benner NL, Keenan KN, ..., Wender P (2020) Prodrugs of PKC modulators show enhanced HIV latency reversal and
an expanded therapeutic window. Proceedings of the National Academy of Sciences of the United States of America.
[IF=2.765, Cited=20, 32371485].
Amaya L, Grigoryan L, Li Z, ..., Chang HY (2023) Circular RNA vaccine induces potent T cell responses. Proceedings of
the National Academy of Sciences of the United States of America. [IF=2.765, Cited=16, 37155869].
Samuel BU, Hearn B, Mack D, ..., McLeod R (2003) Delivery of antimicrobials into parasites. Proceedings of the National
Academy of Sciences of the United States of America. [IF=2.765, Cited=46, 14623959].
Wender P, Cribbs CM, Koehler KF, ..., Blumberg PM (1988) Modeling of the bryostatins to the phorbol ester pharmacophore
on protein kinase C. Proceedings of the National Academy of Sciences of the United States of America. [IF=2.765,
Cited=88, 3174627].
Wender P, Kelly RC, Beckham S, Miller BL (1991) Studies on DNA-cleaving agents: computer modeling analysis of the
mechanism of activation and cleavage of dynemicin-oligonucleotide complexes. Proceedings of the National Academy of
Sciences of the United States of America. [IF=2.765, Cited=7, 1924343].
Wender P, Irie K, Miller BL (1995) Identification, activity, and structural studies of peptides incorporating the
phorbol ester-binding domain of protein kinase C. Proceedings of the National Academy of Sciences of the United States
of America. [IF=2.765, Cited=19, 7816824].
Wender PA, Wender P, DeBrabander J, ..., Pettit GR (1998) The design, computer modeling, solution structure, and
biological evaluation of synthetic analogs of bryostatin 1. Proceedings of the National Academy of Sciences of the
United States of America. [IF=2.765, Cited=47, 9618462].
Wender P, Mitchell DJ, Pattabiraman K, ..., Rothbard JB (2000) The design, synthesis, and evaluation of molecules that
enable or enhance cellular uptake: peptoid molecular transporters. Proceedings of the National Academy of Sciences of
the United States of America. [IF=2.765, Cited=789, 11087855].
Bitnun A, Ransy DG, Brophy J, ..., Soudeyns H (2020) Clinical Correlates of Human Immunodeficiency Virus-1 (HIV-1) DNA
and Inducible HIV-1 RNA Reservoirs in Peripheral Blood in Children With Perinatally Acquired HIV-1 Infection With
Sustained Virologic Suppression for at Least 5 Years. Clinical Infectious Diseases. [IF=2.495, Cited=14, 30919879].
Blazkova J, Whitehead EJ, Schneck R, ..., Chun TW (2024) Immunologic and Virologic Parameters Associated With Human
Immunodeficiency Virus (HIV) DNA Reservoir Size in People With HIV Receiving Antiretroviral Therapy. Journal of
Infectious Diseases. [IF=1.292, Cited=1, 38128541].
Huiting ED, Gittens K, Justement JS, ..., Chun TW (2019) Impact of Treatment Interruption on HIV Reservoirs and
Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection. Journal of
Infectious Diseases. [IF=1.292, Cited=8, 30840763].
Shanmukha S, Godfrey WH, Gharibani P, ..., Kim PM (2024) TPPB modulates PKC activity to attenuate neuroinflammation and
ameliorate experimental multiple sclerosis. None. [IF=None, Cited=0, 38370818].
Shaha SP, Tomic J, Shi Y, ..., Spaner DE (2009) Prolonging microtubule dysruption enhances the immunogenicity of chronic
lymphocytic leukaemia cells. Clinical and Experimental Immunology. [IF=1.013, Cited=17, 19737143].
Wender P, Kee JM, Warrington JM (2008) Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against
latent HIV. Science. [IF=7.729, Cited=74, 18451298].
Wender P, Hardman CT, Ho S, ..., Stevens MC (2017) Scalable synthesis of bryostatin 1 and analogs, adjuvant leads
against latent HIV. Science. [IF=7.729, Cited=35, 29026042].
Neville LF, Shalit I, Warn PA, ..., Rendell JT (2021) In Vivo Targeting of Escherichia coli with Vancomycin-
Arginine. Antimicrobial Agents and Chemotherapy. [IF=1.175, Cited=8, 33468474].
Haabeth OAW, Blake TR, McKinlay CJ, ..., Levy R (2019) Local Delivery of Ox40l, Cd80, and Cd86 mRNA
Kindles Global Anticancer Immunity. Cancer Research. [IF=1.624, Cited=45, 30692215].
Franc BL, Mandl SJ, Siprashvili Z, ..., Contag CH (2003) Breaching biological barriers: protein translocation domains as
tools for molecular imaging and therapy. Molecular Imaging. [IF=0.687, Cited=7, 14717330].
Kennedy BD, Blazkova J, Justement JS, ..., Chun TW (2023) Comprehensive analysis of HIV reservoirs in elite controllers.
Journal of Clinical Investigation. [IF=2.423, Cited=2, 36719383].
Wilk AJ, Weidenbacher NLB, Vergara R, ..., Blish CA (2020) Charge-altering releasable transporters enable phenotypic
manipulation of natural killer cells for cancer immunotherapy. Blood advances. [IF=1.916, Cited=20, 32898247].
Marsden MD, Loy BA, Wu X, ..., Zack JA (2017) In vivo activation of latent HIV with a synthetic bryostatin analog
effects both latent cell "kick" and "kill" in strategy for virus eradication. PLoS Pathogens. [IF=1.423, Cited=52, 28934369].
DeChristopher BA, Fan AC, Felsher DW, Wender P (2012) "Picolog," a synthetically-available bryostatin analog, inhibits
growth of MYC-induced lymphoma in vivo. Oncotarget. [IF=0.666, Cited=22, 22308267].
Dimapasoc M, Moran JA, Cole SW, ..., Zack JA (2024) Defining the Effects of PKC Modulator HIV Latency-Reversing Agents
on Natural Killer Cells. Pathogens and Immunity. [IF=1.129, Cited=0, 38765786].
Robbins PB, Oliver SF, Sheu SM, ..., Khavari PA (2002) Peptide delivery to tissues via reversibly linked protein
transduction sequences. BioTechniques. [IF=0.626, Cited=17, 12139245].
Wender P, Baryza JL, Brenner SE, ..., Meyer T (2004) Function oriented synthesis: the design, synthesis, PKC binding and
translocation activity of a new bryostatin analog. Current Drug Discovery Technologies. [IF=0.519, Cited=22, 16472215].
Shanmukha S, Godfrey WH, Gharibani P, ..., Kim PM (2024) TPPB modulates PKC activity to attenuate neuroinflammation and
ameliorate experimental multiple sclerosis. Frontiers in Cellular Neuroscience. [IF=1.182, Cited=0, 38841204].
Overall SA, Price LE, Albert BJ, ..., Barnes AB (2020) In Situ Detection of Endogenous HIV Activation by Dynamic Nuclear
Polarization NMR and Flow Cytometry. International Journal of Molecular Sciences. [IF=1.263, Cited=9, 32629894].
Wender P, Gamber GG, Scanio MJC (2001) Serial [5+2]/[4+2] Cycloadditions: Facile, Preparative, Multi-Component Syntheses
of Polycyclic Compounds from Simple, Readily Available Starting Materials This research was supported by grant
CHE-9800445 from the National Science Foundation. The Stanford Graduate Fellowship (M.J.C.S. and G.G.G.) is gratefully
acknowledged. Angewandte Chemie - International Edition. [IF=2.456, Cited=0, 11668567].

Publication with MISSING institution:

Wender P (1967) On necessary and sufficient conditions in psychiatric explanation. None. [IF=None, Cited=4, 6015934].
Arnold LE, Wender P, McCloskey K, Snyder SH (1972) Levoamphetamine and dextroamphetamine: comparative efficacy in the
hyperkinetic syndrome. Assessment by target symptoms. None. [IF=None, Cited=45, 4564954].
Wender P, Rosenthal D, Kety SS, ..., Welner J (1973) Social class and psychopathology in adoptees. A natural
experimental method for separating the roles of genetic and experimential factors. None. [IF=None, Cited=13, 4688624].
Greenhill LL, Rieder RO, Wender P, ..., Zhan TP (1973) Lithium carbonate in the treatment of hyperactive children. None.
[IF=None, Cited=33, 4573417].
Buchsbaum M, Wender P (1973) Average evoked responses in normal and minimally brain dysfunctioned children treated with
amphetamine. None. [IF=None, Cited=67, 4795188].
Wender P, Rosenthal D, Kety SS, ..., Welner J (1974) Crossfostering. A research strategy for clarifying the role of
genetic and experiential factors in the etiology of schizophrenia. None. [IF=None, Cited=61, 4808731].
Rieder RO, Rosenthal D, Wender P, Blumenthal H (1975) The offspring of schizophrenics. Fetal and neonatal deaths. None.
[IF=None, Cited=61, 234727].
Zahn TP, Abate F, Little BC, Wender P (1975) Minimal brain dysfunction, stimulant drugs, and autonomic nervous system
activity. None. [IF=None, Cited=53, 1115578].
Rosenthal D, Wender P, Kety SS, ..., Rieder RO (1975) Parent-child relationships and psychopathological disorder in the
child. None. [IF=None, Cited=13, 1119900].
Wood DR, Reimherr FW, Wender P, Johnson GE (1976) Diagnosis and treatment of minimal brain dysfunction in adults: a
preliminary report. None. [IF=None, Cited=132, 793563].
Wender P, Rosenthal D, Rainer JD, ..., Sarlin MB (1977) Schizophrenics' adopting parents. Psychiatric status. None.
[IF=None, Cited=5, 879974].
Haier RJ, Rosenthal D, Wender P (1978) MMPI assessment of psychopathology in the adopted-away offspring of
schizophrenics. None. [IF=None, Cited=6, 623503].
Wender P, Reimherr FW, Wood DR (1981) Attention deficit disorder ('minimal brain dysfunction') in adults. A replication
study of diagnosis and drug treatment. None. [IF=None, Cited=124, 7011250].
Wender P, Reimherr FW, Wood DR (1985) Stimulant therapy of 'adult hyperactivity'. None. [IF=None, Cited=6, 2861798].
Wender P, Kety SS, Rosenthal D, ..., Lunde I (1986) Psychiatric disorders in the biological and adoptive families of
adopted individuals with affective disorders. None. [IF=None, Cited=211, 3753159].
Kety SS, Wender P, Jacobsen B, ..., Kinney DK (1994) Mental illness in the biological and adoptive relatives of
schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark. None. [IF=None, Cited=133, 8192547].
Myles-Worsley M, Coon H, Tiobech J, ..., Byerley W (1999) Genetic epidemiological study of schizophrenia in Palau,
Micronesia: prevalence and familiality. None. [IF=None, Cited=30, 10050960].
Coon H, Sobell J, Heston L, ..., Wender P (1994) Search for mutations in the beta 1 GABAA receptor subunit gene in
patients with schizophrenia. None. [IF=None, Cited=13, 8178835].
Coon H, Jensen S, Holik J, ..., Leppert M (1994) Genomic scan for genes predisposing to schizophrenia. None. [IF=None,
Cited=116, 7909992].
Coon H, Holik J, Hoff M, ..., Byerley W (1994) Analysis of chromosome 22 markers in nine schizophrenia pedigrees. None.
[IF=None, Cited=84, 7909993].
Liu P, Cheong PHY, Yu ZX, ..., Houk KN (2008) Substituent effects, reactant preorganization, and ligand exchange control
the reactivity in Rh(I)-catalyzed (5+2) cycloadditions between vinylcyclopropanes and alkynes. Angewandte Chemie -
International Edition. [IF=2.456, Cited=40, 18412215].
Goun EA, Pillow TH, Jones LR, ..., Wender P (2006) Molecular transporters: synthesis of oligoguanidinium transporters
and their application to drug delivery and real-time imaging. ChemBioChem. [IF=0.691, Cited=92, 16972294].
Coyle JT, Wender P, Lipsky A (1973) Avoidance conditioning in different strains of rats: neurochemical correlates. None.
[IF=None, Cited=25, 4146488].
Zahn TP, Little BC, Wender P (1978) Pupillary and heart rate reactivity in children with minimal brain dysfunction.
None. [IF=None, Cited=19, 632454].
Kety SS, Rosenthal D, Wender P, ..., Jacobsen B (1976) Mental illness in the biological and adoptive families of adopted
individuals who have become schizophrenic. Behavior Genetics. [IF=0.746, Cited=26, 973827].
Yang JW, Wender P (1997) Synthesis of 1-(2-naphthoyl) benzotriazoles as photoactivated DNA cleaving agents. Archives of
Pharmacal Research. [IF=1.342, Cited=1, 18975202].
Jeon R, Wender P (2000) Design and synthesis of new DNA photocleavers, 4'-bromoace-tophenone-pyrrolecarboxamide hybrid
compounds. Archives of Pharmacal Research. [IF=1.342, Cited=0, 11156179].
Jeon R, Wender P (2001) Photocleavage of DNA by 4'-bromoacetophenone analogs. Archives of Pharmacal Research. [IF=1.342,
Cited=0, 11235810].
Retz-Junginger P, Retz W, Blocher D, ..., Rössler M (2002) [Wender Utah rating scale. The short-version for the
assessment of the attention-deficit hyperactivity disorder in adults]. Der Nervenarzt. [IF=0.581, Cited=192, 12215873].
Retz-Junginger P, Retz W, Blocher D, ..., Rösler M (2003) [Reliability and validity of the Wender-Utah-Rating-Scale
short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder]. Der Nervenarzt.
[IF=0.581, Cited=144, 14598035].
Rösler M, Retz W, Retz-Junginger P, ..., Wender P (2008) [Attention deficit hyperactivity disorder in adults.
Benchmarking diagnosis using the Wender-Reimherr adult rating scale]. Der Nervenarzt. [IF=0.581, Cited=38, 18210051].
Retz W, Retz-Junginger P, Hengesch G, ..., Rösler M (2004) Psychometric and psychopathological characterization of young
male prison inmates with and without attention deficit/hyperactivity disorder. European Archives of Psychiatry and
Clinical Neuroscience. [IF=1.39, Cited=44, 15309387].
Rösler M, Retz W, Retz-Junginger P, ..., Thome J (2004) Prevalence of attention deficit-/hyperactivity disorder (ADHD)
and comorbid disorders in young male prison inmates. European Archives of Psychiatry and Clinical Neuroscience.
[IF=1.39, Cited=132, 15538605].
Reimherr FW, Marchant BK, Gift TE, ..., Wender P (2014) Revising the diagnostic criteria for Attention-Deficit
Hyperactivity Disorder (ADHD): an adulthood perspective. ADHD Attention Deficit and Hyperactivity Disorders. [IF=1.545,
Cited=0, 25424046].
Reimherr FW, Marchant BK, Gift TE, ..., Wender P (2015) Types of adult attention-deficit hyperactivity disorder (ADHD):
baseline characteristics, initial response, and long-term response to treatment with methylphenidate. ADHD Attention
Deficit and Hyperactivity Disorders. [IF=1.545, Cited=23, 25987323].
Coon H, Hoff M, Holik J, ..., Byerley W (1996) Analysis of chromosome 18 DNA markers in multiplex pedigrees with manic
depression. Biological Psychiatry. [IF=2.412, Cited=29, 8731455].
Rimmer J, Cole S, Jacobson B, ..., Wender P (1979) Personal and social characteristics differentiating adoptive
relatives of schizophrenics and nonschizophrenics: a preliminary report based on interviews. Comprehensive Psychiatry.
[IF=2.058, Cited=1, 421450].
Feinberg I, Wender P, Koresko RL, ..., Piehuta JA (1969) Differential effects of chlorpromazine and phenobarbital on EEG
sleep patterns. Journal of Psychiatric Research. [IF=1.364, Cited=22, 4318718].
Wender P (1974) Some speculations concerning a possible biochemical basis of minimal brain dysfunction. Life Sciences.
[IF=1.121, Cited=26, 4601632].
Ingraham LJ, Wender P (1992) Risk for affective disorder and alcohol and other drug abuse in the relatives of
affectively ill adoptees. Journal of Affective Disorders. [IF=1.877, Cited=11, 1430667].
Wood D, Reimherr F, Wender P (1982) Effects of levodopa on attention deficit disorder, residual type. Psychiatry
Research. [IF=2.134, Cited=10, 6949167].
Wender P, Wood DR, Reimherr FW, Ward M (1983) An open trial of pargyline in the treatment of attention deficit disorder,
residual type. Psychiatry Research. [IF=2.134, Cited=20, 6359210].
Reimherr FW, Wender P, Ebert MH, Wood DR (1984) Cerebrospinal fluid homovanillic acid and 5-hydroxy-indoleacetic acid in
adults with attention deficit disorder, residual type. Psychiatry Research. [IF=2.134, Cited=18, 6200893].
Wood DR, Reimherr FW, Wender P (1985) Treatment of attention deficit disorder with DL-phenylalanine. Psychiatry
Research. [IF=2.134, Cited=15, 3903813].
Myles-Worsley M, Johnston WA, Wender P (1991) Spontaneous selective attention in schizophrenia. Psychiatry Research.
[IF=2.134, Cited=4, 1798817].
Waldo MC, Carey G, Myles-Worsley M, ..., Freedman R (1991) Codistribution of a sensory gating deficit and schizophrenia
in multi-affected families. Psychiatry Research. [IF=2.134, Cited=69, 1798824].
Rothbard JB, Jessop TC, Wender P (2005) Adaptive translocation: the role of hydrogen bonding and membrane potential in
the uptake of guanidinium-rich transporters into cells. Advanced Drug Delivery Reviews. [IF=2.563, Cited=133, 15722160].
Baryza JL, Brenner SE, Craske ML, ..., Wender P (2004) Simplified analogs of bryostatin with anticancer activity display
greater potency for translocation of PKCdelta-GFP. None. [IF=None, Cited=14, 15380186].
Stang SL, Lopez-Campistrous A, Song X, ..., Stone JC (2009) A proapoptotic signaling pathway involving RasGRP, Erk, and
Bim in B cells. Experimental Hematology. [IF=0.67, Cited=29, 19100522].
Lopez-Campistrous A, Song X, Schrier AJ, ..., Stone JC (2012) Bryostatin analogue-induced apoptosis in mantle cell
lymphoma cell lines. Experimental Hematology. [IF=0.67, Cited=3, 22465296].
Khan TK, Nelson TJ, Verma VA, ..., Alkon DL (2009) A cellular model of Alzheimer's disease therapeutic efficacy: PKC
activation reverses Abeta-induced biomarker abnormality on cultured fibroblasts. Neurobiology of Disease. [IF=1.245,
Cited=39, 19233276].
Garfinkel BD, Wender P, Sloman L, O'Neill I (1983) Tricyclic antidepressant and methylphenidate treatment of attention
deficit disorder in children. None. [IF=None, Cited=36, 6875128].
Wender P (1973) Minimal brain dysfunction in children. Diagnosis and management. Pediatric Clinics of North America.
[IF=1.49, Cited=7, 4581984].
Wender P (1969) Platelet-serotonin level in children with "minimal brain dysfunction". The Lancet. [IF=25.787,
Cited=11, 4186965].
Nakagawa Y, Irie K, Ohigashi H, ..., Wender P (2000) Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a
new thioamide analogue of tumor promoting indolactam-V. Bioorganic and Medicinal Chemistry Letters. [IF=0.704, Cited=7, 10999477].
Tanaka M, Irie K, Nakagawa Y, ..., Wender P (2001) The C4 hydroxyl group of phorbol esters is not necessary for protein
kinase C binding. Bioorganic and Medicinal Chemistry Letters. [IF=0.704, Cited=4, 11266177].
Irie K, Nakahara A, Ohigashi H, ..., Kikkawa U (1999) Synthesis and phorbol ester-binding studies of the individual
cysteine-rich motifs of protein kinase D. Bioorganic and Medicinal Chemistry Letters. [IF=0.704, Cited=10, 10498194].
Shindo M, Irie K, Nakahara A, ..., Wender P (2001) Toward the identification of selective modulators of protein kinase C
(PKC) isozymes: establishment of a binding assay for PKC isozymes using synthetic C1 peptide receptors and
identification of the critical residues involved in the phorbol ester binding. Bioorganic and Medicinal Chemistry.
[IF=0.86, Cited=42, 11504643].
Irie K, Yanai Y, Oie K, ..., Kikkawa U (1997) Comparison of chemical characteristics of the first and the second
cysteine-rich domains of protein kinase C gamma. Bioorganic and Medicinal Chemistry. [IF=0.86, Cited=16, 9313873].
Fukuda H, Irie K, Nakahara A, ..., Wender P (1999) Solid-phase synthesis, mass spectrometric analysis of the zinc-
folding, and phorbol ester-binding studies of the 116-mer peptide containing the tandem cysteine-rich C1 domains of
protein kinase C gamma. Bioorganic and Medicinal Chemistry. [IF=0.86, Cited=13, 10428394].
Chen L, Wright LR, Chen CH, ..., Mochly-Rosen D (2001) Molecular transporters for peptides: delivery of a
cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). None.
[IF=None, Cited=94, 11755391].
Benner NL, Near KE, Bachmann MH, ..., Wender PA (2018) Functional DNA Delivery Enabled by Lipid-Modified Charge-Altering
Releasable Transporters (CARTs). Biomacromolecules. [IF=1.112, Cited=16, 29727572].
Benner NL, Zang X, Buehler DC, ..., Wender P (2017) Vault Nanoparticles: Chemical Modifications for Imaging and Enhanced
Delivery. ACS Nano. [IF=2.423, Cited=18, 28029784].
Singh J, Ripp A, Haas TM, ..., Jessen HJ (2019) Correction to "Synthesis of Modified Nucleoside Oligophosphates
Simplified: Fast, Pure, and Protecting Group Free". Journal of the American Chemical Society. [IF=2.573, Cited=0, 31580654].
Marchant BK, Reimherr FW, Robison D, ..., Wender P (2013) Psychometric properties of the Wender-Reimherr Adult Attention
Deficit Disorder Scale. Psychological Assessment. [IF=2.326, Cited=29, 23647041].
Rothbard JB, Garlington S, Lin Q, ..., Khavari PA (2000) Conjugation of arginine oligomers to cyclosporin A facilitates
topical delivery and inhibition of inflammation. Nature Medicine. [IF=11.877, Cited=313, 11062537].
DeChristopher BA, Loy BA, Marsden MD, ..., Wender P (2012) Designed, synthetically accessible bryostatin analogues
potently induce activation of latent HIV reservoirs in vitro. Nature Chemistry. [IF=3.667, Cited=118, 22914190].
Statsuk AV, Bai R, Baryza JL, ..., Kozmin SA (2005) Actin is the primary cellular receptor of bistramide A. Nature
Chemical Biology. [IF=2.623, Cited=33, 16372404].
Coon H, Myles-Worsley M, Tiobech J, ..., Byerley W (1998) Evidence for a chromosome 2p13-14 schizophrenia susceptibility
locus in families from Palau, Micronesia. Molecular Psychiatry. [IF=2.603, Cited=48, 9857978].
Devlin B, Bacanu SA, Roeder K, ..., Byerley W (2002) Genome-wide multipoint linkage analyses of multiplex schizophrenia
pedigrees from the oceanic nation of Palau. Molecular Psychiatry. [IF=2.603, Cited=50, 12192612].
Wender P, Koehler KF, Sharkey NA, ..., Blumberg PM (1986) Analysis of the phorbol ester pharmacophore on protein kinase
C as a guide to the rational design of new classes of analogs. Proceedings of the National Academy of Sciences of the
United States of America. [IF=2.765, Cited=56, 3086877].
Wender P (1968) Vicious and virtuous circles: the role of deviation amplifying feedback in the origin and perpetuation
of behavior. Psychiatry (New York). [IF=0.95, Cited=8, 5683756].
Siprashvili Z, Scholl FA, Oliver SF, ..., Khavari PA (2003) Gene transfer via reversible plasmid condensation with
cysteine-flanked, internally spaced arginine-rich peptides. Human Gene Therapy. [IF=0.819, Cited=39, 12952594].
Wender P (1993) Methamphetamine in child psychiatry. Journal of Child and Adolescent Psychopharmacology. [IF=0.824,
Cited=1, 19630590].
Blazkova J, Chun TW, Belay BW, ..., Fauci AS (2012) Effect of histone deacetylase inhibitors on HIV production in
latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy. Journal
of Infectious Diseases. [IF=1.292, Cited=80, 22732922].
Kety SS, Rosenthal D, Wender P, Schulsinger F (1976) Studies based on a total sample of adopted individuals and their
relatives: why they were necessary, what they demonstrated and failed to demonstrate. Schizophrenia Bulletin. [IF=1.951,
Cited=15, 1006193].
Hammond C, Shi Y, Mena J, ..., Spaner DE (2005) Effect of serum and antioxidants on the immunogenicity of protein kinase
C-activated chronic lymphocytic leukemia cells. Journal of Immunotherapy. [IF=0.92, Cited=13, 15614042].
Wender P, Ward MF, Reimherr FW, Marchant BK (2000) ADHD in adults. Journal of the American Academy of Child and
Adolescent Psychiatry. [IF=3.59, Cited=8, 10802966].
Wender P (1972) The minimal brain dysfunction syndrome in children. I. The syndrome and its relevance for psychiatry.
II. A psychological and biochemical model for the syndrome. Journal of Nervous and Mental Disease. [IF=0.802, Cited=45, 4402515].
Coon H, Hicks AA, Bailey ME, ..., Wender P (1994) Analysis of GABAA receptor subunit genes in multiplex pedigrees with
manic depression. Psychiatric Genetics. [IF=0.682, Cited=13, 7719705].
Byerley W, Bailey ME, Hicks AA, ..., Wender P (1995) Schizophrenia and GABAA receptor subunit genes. Psychiatric
Genetics. [IF=0.682, Cited=8, 7582877].
Fang N, Coon H, Hoff M, ..., Freedman R (1995) Search for a schizophrenia susceptibility gene on chromosome 18.
Psychiatric Genetics. [IF=0.682, Cited=5, 7582878].
Jensen J, Coon H, Hoff M, ..., Byerley W (1998) Search for a schizophrenia susceptibility gene on chromosome 13.
Psychiatric Genetics. [IF=0.682, Cited=1, 9861643].
Gift TE, Reimherr FW, Marchant BK, ..., Wender P (2016) Personality Disorder in Adult Attention-Deficit/Hyperactivity
Disorder: Attrition and Change During Long-term Treatment. Journal of Nervous and Mental Disease. [IF=0.802, Cited=3, 27082828].
Haabeth OAW, Lohmeyer JJK, Sallets A, ..., Levy R (2021) An mRNA SARS-CoV-2 vaccine employing Charge-Altering Releasable
Transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory. None. [IF=None, Cited=0, 33880472].
Wender P (1973) Some speculations concerning a possible biochemical basis of minimal brain dysfunction. Annals of the
New York Academy of Sciences. [IF=1.878, Cited=20, 4570233].
Wender P, Pedersen FA, Waldrop MF (1967) A longitudinal study of early social behavior and cognitive development.
American Journal of Orthopsychiatry. [IF=1.532, Cited=1, 6033423].
Wender P (1969) The role of genetics in the etiology of the schizophrenias. American Journal of Orthopsychiatry.
[IF=1.532, Cited=2, 4891115].
Eldred CA, Rosenthal D, Wender P, ..., Jacobsen B (1976) Some aspects of adoption in selected samples of adult adoptees.
American Journal of Orthopsychiatry. [IF=1.532, Cited=8, 1266951].
Schell MA, Wender P (1986) Identification of the nahR gene product and nucleotide sequences required for its activation
of the sal operon. Journal of Bacteriology. [IF=0.898, Cited=43, 3007442].
Wender P (1975) The minimal brain dysfunction syndrome. Annual Review of Medicine. [IF=3.155, Cited=17, 1096774].
Byerley W, Plaetke R, Hoff M, ..., Leppert M (1992) Tyrosine hydroxylase gene not linked to manic-depression in seven of
eight pedigrees. Human Heredity. [IF=0.512, Cited=25, 1355073].
Jensen S, Plaetke R, Holik J, ..., Litt M (1992) Linkage analysis of the D1 dopamine receptor gene and manic depression
in six families. Human Heredity. [IF=0.512, Cited=15, 1360940].
Hadley D, Hoff M, Holik J, ..., Byerley W (1995) Manic-depression and the norepinephrine transporter gene. Human
Heredity. [IF=0.512, Cited=13, 7615302].
Wender P (1981) Psychiatric genetics and the primary prevention of psychiatric disorders. None. [IF=None, Cited=0, 7458888].
Orne MT, Wender P (1968) Anticipatory socialization for psychotherapy: method and rationale. American Journal of
Psychiatry. [IF=3.582, Cited=45, 5637908].
Wender P, Epstein RS, Kopin IJ, Gordon EK (1971) Urinary monoamine metabolites in children with minimal brain
dysfunction. American Journal of Psychiatry. [IF=3.582, Cited=26, 5549938].
Wender P, Rosenthal D, Zahn TP, Kety SS (1971) The psychiatric adjustment of the adopting parents of schizophrenics.
American Journal of Psychiatry. [IF=3.582, Cited=8, 5099941].
Freedman DE, Kety SS, Rosenthal D, ..., Schulsinger F (1972) The significance of genetics in schizophrenia. American
Journal of Psychiatry. [IF=3.582, Cited=0, 5020202].
Kety SS, Rosenthal D, Wender P, Schulsinger F (1971) Mental illness in the biological and adoptive families of adpoted
schizophrenics. American Journal of Psychiatry. [IF=3.582, Cited=74, 5570994].
Rosenthal D, Wender P, Kety SS, ..., Schulsinger F (1971) The adopted-away offspring of schizophrenics. American Journal
of Psychiatry. [IF=3.582, Cited=83, 5570995].
Wender EH, Palmer FB, Herbst JJ, Wender P (1976) Behavioral characteristics of children with chronic nonspecific
diarrhea. American Journal of Psychiatry. [IF=3.582, Cited=8, 55080].
Reimherr FW, Wood DR, Wender P (1980) An open clinical trial of L-dopa and carbidopa in adults with minimal brain
dysfunction. American Journal of Psychiatry. [IF=3.582, Cited=9, 6986093].
Wender P (1981) The Danish-American studies: critiquing the critique. American Journal of Psychiatry. [IF=3.582,
Cited=0, 7294207].
Wood D, Wender P, Reimherr FW (1983) The prevalence of attention deficit disorder, residual type, or minimal brain
dysfunction, in a population of male alcoholic patients. American Journal of Psychiatry. [IF=3.582, Cited=50, 6847993].
Wender P, Kalm M (1983) Prevalence of attention deficit disorder, residual type, and other psychiatric disorders in
patients with irritable colon syndrome. American Journal of Psychiatry. [IF=3.582, Cited=13, 6650687].
Wender P, Reimherr FW, Wood D, Ward M (1985) A controlled study of methylphenidate in the treatment of attention deficit
disorder, residual type, in adults. American Journal of Psychiatry. [IF=3.582, Cited=94, 3885760].
Wender P (1986) Concurrent therapy with d-amphetamine and adrenergic drugs. American Journal of Psychiatry. [IF=3.582,
Cited=1, 3946671].
Reimherr FW, Wender P, Wood DR, Ward M (1987) An open trial of L-tyrosine in the treatment of attention deficit
disorder, residual type. American Journal of Psychiatry. [IF=3.582, Cited=16, 3300376].
Ward MF, Wender P, Reimherr FW (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood
attention deficit hyperactivity disorder. American Journal of Psychiatry. [IF=3.582, Cited=734, 8494063].
Klein DF, Wender P (1995) Understanding depression. American Journal of Psychiatry. [IF=3.582, Cited=0, 7694931].
Mirdal GM, Rosenthal D, Wender P, Schulsinger F (1977) Perinatal complications in offspring of psychotic parents.
British Journal of Psychiatry. [IF=2.644, Cited=4, 861431].
Irie K, Nakahara A, Ikawa Y, ..., Wender P (2000) Synthesis and tumor-promoting activities of 12-Epi-
phorbol-12,13-dibutyrate. Bioscience, Biotechnology and Biochemistry. [IF=0.523, Cited=4, 11193412].
Wright LR, Rothbard JB, Wender P (2003) Guanidinium rich peptide transporters and drug delivery. Current Protein and
Peptide Science. [IF=0.718, Cited=40, 12678850].
Olsen JL, Reimherr FW, Marchant BK, ..., Robison RJ (2012) The effect of personality disorder symptoms on response to
treatment with methylphenidate transdermal system in adults with attention-deficit/hyperactivity disorder. None.
[IF=None, Cited=7, 23469326].
Wender P (1975) A possible monoaminergic basis for minimal brain dysfunction. Psychopharmacology Bulletin. [IF=0.27,
Cited=0, 1153658].
Reimherr FW, Strong RE, Marchant BK, ..., Wender P (2001) Factors affecting return of symptoms 1 year after treatment in
a 62-week controlled study of fluoxetine in major depression. Journal of Clinical Psychiatry. [IF=1.524, Cited=0, 11599643].
Kety SS, Rosenthal D, Wender P, ..., Jacobsen B (1975) Mental illness in the biological and adoptive families of adopted
individuals who have become schizophrenic: a preliminary report based on psychiatric interviews. None. [IF=None,
Cited=0, 1242222].
Marchant BK, Reimherr FW, Wender P, Gift TE (2015) Psychometric properties of the Self-Report Wender-Reimherr Adult
Attention Deficit Disorder Scale. Annals of Clinical Psychiatry. [IF=0.569, Cited=0, 26554368].
Reimherr FW, Byerley WF, Ward MF, ..., Wender P (1988) Sertraline, a selective inhibitor of serotonin uptake, for the
treatment of outpatients with major depressive disorder. Psychopharmacology Bulletin. [IF=0.27, Cited=0, 3290941].
Reimherr FW, Wood DR, Wender P (1986) The use of MK-801, a novel sympathomimetic, in adults with attention deficit
disorder, residual type. Psychopharmacology Bulletin. [IF=0.27, Cited=0, 3523579].
Wood DR, Reimherr FW, Wender P (1985) Amino acid precursors for the treatment of attention deficit disorder, residual
type. Psychopharmacology Bulletin. [IF=0.27, Cited=0, 3885291].
Wender P, Wood DR, Reimherr FW (1985) Pharmacological treatment of attention deficit disorder, residual type (ADD,RT,
"minimal brain dysfunction," "hyperactivity") in adults. Psychopharmacology Bulletin. [IF=0.27, Cited=0, 3923527].
Wender P (1974) Proceedings: Some speculations concerning a possible biochemical basis of minimal brain dysfunction.
Psychopharmacology Bulletin. [IF=0.27, Cited=0, 4471620].
Wender P (1973) Genetics and schizophrenia. JAMA - Journal of the American Medical Association. [IF=13.276, Cited=0, 4739404].
Pedersen FA, Wender P (1968) Early social correlates of cognitive functioning in six-year-old boys. Child Development.
[IF=2.441, Cited=0, 5645795].
Wender P (1967) Communicative unclarity: some comments on the rhetoric of confusion. Psychiatry (New York). [IF=0.95,
Cited=0, 6062582].
Wender P, Wood D, Reimherr F (1984) Studies in attention deficit disorder, residual type (minimal brain dysfunction in
adults). Psychopharmacology Bulletin. [IF=0.27, Cited=0, 6718645].
Coon H, Jensen S, Hoff M, ..., Byerley W (1993) A genome-wide search for genes predisposing to manic-depression,
assuming autosomal dominant inheritance. American Journal of Human Genetics. [IF=2.607, Cited=0, 8503452].
Hedges D, Reimherr FW, Rogers A, ..., Wender P (1995) An open trial of venlafaxine in adult patients with attention
deficit hyperactivity disorder. Psychopharmacology Bulletin. [IF=0.27, Cited=0, 8851653].
Zuckerman R, Wender P, Wender EH (1976) Letter: Minimal brain dysfunction myth. None. [IF=None, Cited=0, 941891].

Wender, Paul

Publication with MATCHING institution:

Publication with MISMATCHING institution:

Publication with MISSING institution: